OCMX Listing
On 6ix: 6ix.com/news/ocmx-listing
The original release is unavailable here.
CanaQuest Medical Corporation on 6ix
Earlier from CanaQuest Medical
- Update: CanaQuest Medical corp files provisional Patent for Mentanine® - omega-3 & pure cannabidiol (“CBD”) formulation boosting mental health efficacy while minimizing CBD dosage
- Canaquest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®
- CanQuest interview with Stock Day Podcast - NOv 25, 2019
- CANAQUEST MEDICAL CORP is the Winner of the Go Global Awards "Business of the Year – Category of Life Science” presented by the International Trade Council
- CanaQuest has developed a safer THC medical cannabis formulation (Metabinol™) from research and pre-clinical trials at Western University, London, Ontario, Canada
Later from CanaQuest Medical
- CanaQuest Medical corp secures approval for listing on the OCMX™, an online investor and financial connection portal
- CanaQuest announces Mentabinol® a scientific discovery, as published in The Journal of Neuroscience
- CanaQuest president interviewed by the wall street analyzer
- CanaQuest signs Mentanine® and Mentabinol® production and distribution agreement with PurCann Pharma and SiliCycle Inc.
- CanaQuest signs medicinal cannabis education partnership with the canadian cannabis dispute resolution centre
Follow CanaQuest Medical into a list and get an email when it puts out news.
Follow CanaQuest Medical